Education
About Us
Working with TipRanks
Follow Us
Marinus Pharmaceuticals Inc (MRNS)
NASDAQ:MRNS
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 30.99M | $ 25.48M | $ 15.35M | $ 1.72M | $ 0.00 |
| Gross Profit | $ 29.05M | $ 25.14M | $ 13.87M | $ -48.79M | $ -503.00K |
| Operating Income | $ -131.49M | $ -112.79M | $ -96.93M | $ -67.94M | $ -54.42M |
| EBITDA | $ -125.50M | $ -5.09M | $ -95.53M | $ -66.88M | $ -54.42M |
| Net Income | $ -141.41M | $ -19.82M | $ -101.66M | $ -66.64M | $ -53.77M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 150.29M | $ 240.55M | $ 122.93M | $ 138.51M | $ 91.68M |
| Total Assets | $ 170.91M | $ 259.52M | $ 136.84M | $ 150.46M | $ 98.84M |
| Total Debt | $ 110.36M | $ 72.67M | $ 40.81M | $ 510.00K | $ 446.00K |
| Net Debt | $ -10.21M | $ -167.88M | $ -82.12M | $ -138.00M | $ -90.50M |
| Total Liabilities | $ 154.14M | $ 143.52M | $ 83.35M | $ 13.26M | $ 11.07M |
| Stockholders' Equity | $ 16.77M | $ 116.00M | $ 53.49M | $ 137.20M | $ 87.77M |
| Cash Flow | |||||
| Free Cash Flow | $ -118.12M | $ -114.66M | $ -58.37M | $ -60.91M | $ -49.02M |
| Operating Cash Flow | $ -118.00M | $ -112.89M | $ -55.48M | $ -60.91M | $ -48.63M |
| Investing Cash Flow | $ -28.61M | $ 105.77M | $ -1.42M | $ -738.00K | $ 3.88M |
| Financing Cash Flow | $ 26.63M | $ 124.74M | $ 41.31M | $ 109.22M | $ 67.97M |